![]() |
市場調查報告書
商品編碼
1494466
北美助聽器市場預測至 2030 年 - 區域分析 - 按類型、產品類型、技術、聽力損失類型、患者類型和配銷通路North America Hearing Aids Market Forecast to 2030 - Regional Analysis - by Type, Product Type, Technology, Type Of Hearing Loss, Patient Type, and Distribution Channel |
2022年北美助聽器市值為102.2281億美元,預計2030年將達到154.5297億美元;預計2022年至2030年複合年成長率為5.3%。
聽力損失發生率上升推動北美助聽器市場
聽力損失深刻影響人類經驗的各個層面,包括身體、情緒和心理健康。老年人口的增加導致聽力損失人數不斷增加,因為這個年齡層的聽力損失風險較高。根據世界衛生組織 (WHO) 統計,到 2020 年,全球 60 歲以上人口將接近 10 億,預計到 2030 年底將達到 14 億,到 2050 年將達到 21 億。人口(4.32 億人)將需要復健治療來解決聽力損失問題,預計到2050 年底這一數字將超過7 億。暴露在過度噪音中是數百萬美國年輕人和老年人聽力損失的主要原因之一。短期和重複的噪音暴露都會對內耳造成持久損害,導致永久性聽力損失。對於在噪音環境中工作的人來說,這是一個特別的風險。根據美國聽力損失協會 (HLAA) 的《聽力損失事實與統計》,每年約有 2,200 萬名美國工人在工作場所暴露在危險的噪音水平下。同一消息來源進一步指出,該國五分之一的男性和八分之一的女性報告有聽力問題。如果不及時治療,聽力損失會隨著時間的推移而惡化。助聽器可以透過提供可能因聽力損失而流失或減少的聽覺刺激來顯著改善個人的生活品質。因此,聽力損失盛行率的上升,無論是全部還是部分,是推動人們對助聽器設備需求的關鍵因素,從而推動助聽器市場的成長。
北美助聽器市場概況
根據美國國家耳聾和其他溝通障礙研究所的數據,到2021 年,約3,000 萬人(佔12 歲及以上美國人口的13%)出現單耳或雙耳聽力損失。患有聽力損失。該國擁有全球領先的市場參與者,專注於產品開發和發布。此外,FDA 對 OTC 助聽器的批准預計將在市場上創造充足的機會。 2023 年 10 月,Audien Hearing 推出了世界上第一款符合 FDA 標準的非處方 (OTC) 助聽器——ATOM ONE,售價不到 100 美元。購買適合他們或他們所愛之人需求的經濟型設備。 2023年10月,人工智慧助聽器和音訊解決方案供應商ELEHEAR推出了首款OTC助聽設備-ELEHEAR Alpha和ELEHEAR Alpha Pro。因此,大量人群中聽力障礙的盛行率不斷上升、新產品的推出以及以經濟的價格提供非處方助聽器有利於美國市場的成長。
北美助聽器市場收入及 2030 年預測(百萬美元)
北美助聽器市場細分
北美助聽器市場根據類型、產品類型、技術、聽力損失類型、患者類型、配銷通路和國家進行細分。根據類型,北美助聽器市場分為處方助聽器和非處方助聽器。處方助聽器細分市場到 2022 年將佔據更大的市場。
從產品類型來看,北美助聽器市場分為助聽器和聽力植入物。到 2022 年,助聽設備細分市場將佔據更大的市場佔有率。 (RITE)助聽器、耳道助聽器等。此外,聽力植入物部分分為耳蝸植入物和骨傳導植入物。
依技術分類,北美助聽器市場分為傳統助聽器和數位助聽器。到 2022 年,傳統助聽器細分市場將佔據更大的市場佔有率。
根據聽力損失的類型,北美助聽器市場分為感音神經性聽力損失和傳導性聽力損失。 2022 年,感音神經性聽損細分市場將佔據更大的市場。
根據患者類型,北美助聽器市場分為成人和兒童。 2022 年,成人細分市場佔據更大的市場佔有率。
根據配銷通路,北美助聽器市場分為藥局、零售店和網路。 2022 年,藥局領域佔據最大的市場佔有率。
根據國家/地區,北美助聽器市場分為美國、加拿大和墨西哥。 2022年,美國在北美助聽器市場佔有率中佔據主導地位。
Starkey Laboratories Inc.、Audina Hearing Instruments Inc.、Sebotek Hearing Systems LLC、Earlens Corp、GN Store Nord AS、Cochlear Ltd、WS Audiology AS、Sonova Holding AG、Sonic Innovations Inc 和 Amplifon Hearing Health Care Corp. 是一些領先的公司在北美助聽器市場營運的公司。
The North America hearing aids market was valued at US$ 10,222.81 million in 2022 and is expected to reach US$ 15,452.97 million by 2030; it is estimated to register a CAGR of 5.3% from 2022 to 2030.
Rising Incidence of Hearing Loss Fuels North America Hearing Aids Market
Hearing loss profoundly impacts every dimension of the human experience, including physical, emotional, and mental health. The rising geriatric population contributes to the growing number of people with hearing loss, as the risk of hearing loss is higher in this age group. According to the World Health Organization (WHO), there were nearly 1 billion people in 2020 aged 60 years and above globally, which is expected to reach 1.4 billion by the end of 2030 and is projected to reach 2.1 billion by 2050. As per WHO, ~5% of the global population (432 million people) will require rehabilitation to address their hearing loss in 2023, which is expected to reach over 700 million by the end of 2050. Although hearing loss is more common among aged people, people of all ages can be affected. Exposure to excessive noise is one of the leading causes of hearing loss for millions of young and old Americans. Both short-term and repeated noise exposure can cause lasting damage to the inner ear, resulting in permanent hearing loss. It's a particular risk for people working around loud noises. According to the Hearing Loss Association of America (HLAA), Hearing Loss Facts and Statistics, ~22 million US workers are exposed to dangerous noise levels in their workplaces yearly. The same source further stated that one out of five men and one of eight women in the country report hearing trouble. When left untreated, hearing loss can worsen with time. Hearing aids can significantly improve an individual's quality of life by providing auditory stimuli that could have been lost or reduced due to loss of hearing. Thus, the rising prevalence of hearing loss, wholly or partially, is a key factor boosting the demand for hearing aid devices among the population, thereby driving the growth of the hearing aids market.
North America Hearing Aids Market Overview
As per the National Institute on Deafness and Other Communication Disorders, ~30 million people or 13% of the US population aged 12 years and above was experiencing hearing loss in one or both ears in 2021. As per the same source, ~28.8 million people in the US could benefit from the use of hearing aids. Country has presence of the leading global market players, which are focused on product development and launches. Furthermore, FDA approval for OTC hearing aids is expected to create ample opportunities in the market. In October 2023, Audien Hearing launched the world's first FDA-compliant hearing aid sold over-the-counter (OTC)-ATOM ONE-for less than US$ 100. The ATOM ONE would allow millions of people suffering from hearing loss to walk in and purchase an economical device suiting their or their loved ones' needs. In October 2023, ELEHEAR, a provider of AI-powered hearing aids and audio solutions, introduced its first OTC hearing aid devices-the ELEHEAR Alpha and ELEHEAR Alpha Pro. Therefore, increasing prevalence of hearing impairment among large populations, new product launches, and availability of OTC hearing aids at economical pricing favors the market growth in the US.
North America Hearing Aids Market Revenue and Forecast to 2030 (US$ Million)
North America Hearing Aids Market Segmentation
The North America hearing aids market is segmented based on type, product type, technology, type of hearing loss, patient type, distribution channel, and country. Based on type, the North America hearing aids market is bifurcated into prescription hearing aids and OTC hearing aids. The prescription hearing aids segment held a larger market share in 2022.
In terms of product type, the North America hearing aids market is bifurcated into hearing aid devices and hearing implants. The hearing aid devices segment held a larger market share in 2022. Furthermore, the hearing aid devices segment is subsegmented into behind-the-ear (BTE) hearing aid, in-the-ear (ITE) hearing aid, receiver-in-the-ear (RITE) hearing aid, canal hearing aid, and others. Additionally, the hearing implants segment is bifurcated into cochlear implants and bone conduction implants.
By technology, the North America hearing aids market is bifurcated into conventional hearing aids and digital hearing aids. The conventional hearing aids segment held a larger market share in 2022.
Based on type of hearing loss, the North America hearing aids market is bifurcated into sensorineural hearing loss and conductive hearing loss. The sensorineural hearing loss segment held a larger market share in 2022.
Based on patient type, the North America hearing aids market is bifurcated into adults and pediatric. The adults segment held a larger market share in 2022.
Based on distribution channel, the North America hearing aids market is segmented into pharmacies, retail stores, and online. The pharmacies segment held the largest market share in 2022.
Based on country, the North America hearing aids market is segmented into the US, Canada, and Mexico. The US dominated the North America hearing aids market share in 2022.
Starkey Laboratories Inc., Audina Hearing Instruments Inc, Sebotek Hearing Systems LLC, Earlens Corp, GN Store Nord AS, Cochlear Ltd, WS Audiology AS, Sonova Holding AG, Sonic Innovations Inc, and Amplifon Hearing Health Care Corp. are some of the leading companies operating in the North America hearing aids market.